Tianxin Yang Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2017	Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin-angiotensin system.
1/2015	Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tianxin Yang Research Topics

Disease

26	Hypertension (High Blood Pressure) 01/2023 - 06/2005
20	Neoplasms (Cancer) 01/2020 - 01/2007
10	Inflammation (Inflammations) 01/2022 - 01/2011
10	Fibrosis (Cirrhosis) 01/2022 - 07/2012
8	Proteinuria 01/2023 - 01/2010
6	Body Weight (Weight, Body) 11/2015 - 06/2005
5	Polyuria 01/2023 - 12/2009
5	Type 2 Diabetes Mellitus (MODY) 12/2015 - 01/2008
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015 - 01/2015
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016 - 01/2013
4	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 04/2004
4	Mitochondrial Diseases (Mitochondrial Disease) 08/2013 - 05/2011
3	Polydipsia 01/2023 - 03/2016
3	Kidney Diseases (Kidney Disease) 11/2022 - 01/2016
3	Obesity 01/2021 - 01/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2015
3	Necrosis 01/2020 - 01/2015
3	Neoplasm Metastasis (Metastasis) 07/2019 - 05/2015
3	Leukemia 01/2019 - 01/2015
3	Dehydration (Water Stress) 01/2019 - 08/2005
3	Diabetes Insipidus 11/2018 - 03/2016
3	Ischemia 03/2017 - 10/2008
2	Hypertrophy 01/2023 - 10/2020
2	Neuromyelitis Optica (Devic's Disease) 03/2021 - 06/2020
2	Chronic Renal Insufficiency 01/2021 - 11/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2010
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 01/2019
2	Albuminuria 01/2020 - 12/2013
2	Chronic Disease (Chronic Diseases) 12/2019 - 01/2017
2	Nephrogenic Diabetes Insipidus 01/2019 - 11/2017
2	Insulin Resistance 06/2018 - 01/2018
2	Lymphoma (Lymphomas) 11/2016 - 01/2015
2	Edema (Dropsy) 11/2015 - 06/2005
2	Disease Progression 10/2015 - 01/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 03/2014
2	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2015
2	Infections 01/2015 - 10/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 01/2015

Drug/Important Bio-Agent (IBA)

15	Prorenin ReceptorIBA 01/2023 - 04/2015
12	SaltsIBA 01/2023 - 11/2006
12	Angiotensin IIIBA 01/2023 - 11/2008
9	ReninIBA 01/2023 - 07/2014
9	Proteins (Proteins, Gene)FDA Link 06/2020 - 10/2007
8	SodiumIBA 01/2017 - 11/2006
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 06/2006
6	AldosteroneIBA 01/2023 - 05/2011
6	Desoxycorticosterone Acetate (DOCA)FDA Link 10/2020 - 10/2008
6	p38 Mitogen-Activated Protein KinasesIBA 11/2016 - 01/2015
5	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 05/2007
5	Prostaglandin-E SynthasesIBA 01/2013 - 12/2009
4	Dinoprostone (PGE2)FDA Link 12/2019 - 11/2008
4	Aurora Kinase AIBA 11/2016 - 01/2015
4	AcidsIBA 01/2015 - 07/2007
4	plumbaginIBA 01/2015 - 03/2014
4	CXA-10IBA 12/2013 - 10/2008
4	Prostaglandins EIBA 01/2013 - 12/2009
3	Desoxycorticosterone (Deoxycorticosterone)IBA 10/2020 - 07/2011
3	Acetates (Acetic Acid Esters)FDA Link 10/2020 - 07/2011
3	CalciumIBA 01/2020 - 01/2019
3	CytokinesIBA 01/2020 - 02/2010
3	LithiumIBA 01/2019 - 12/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 01/2013
3	MLN 8237IBA 01/2015 - 01/2015
3	ThiazolidinedionesIBA 11/2013 - 06/2006
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 01/2015
2	Hexosaminidases (Hexosaminidase)IBA 01/2022 - 12/2018
2	CreatinineIBA 01/2022 - 01/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 10/2008
2	LigandsIBA 01/2021 - 01/2015
2	site 1 membrane-bound transcription factor peptidaseIBA 01/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 12/2013
2	CateninsIBA 11/2020 - 01/2015
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2020 - 06/2005
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2019
2	Butyric Acid (Butanoic Acid)IBA 12/2019 - 01/2017
2	Riboflavin (Vitamin B2)FDA LinkGeneric 10/2019 - 07/2019
2	GYY 4137IBA 01/2019 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 06/2018 - 01/2018
2	Vasopressins (Vasopressin)IBA 11/2017 - 03/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2015
2	danusertibIBA 11/2016 - 01/2015
2	Aurora KinasesIBA 11/2016 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2016 - 08/2005
2	Coloring Agents (Dyes)IBA 01/2016 - 02/2012
2	Insulin (Novolin)FDA Link 12/2015 - 01/2008
2	Therapeutic UsesIBA 12/2015 - 01/2015
2	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2015 - 10/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2015 - 02/2015
2	Antineoplastic Agents (Antineoplastics)IBA 05/2015 - 01/2015
2	Beclin-1IBA 01/2015 - 01/2015
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 01/2015
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2015 - 01/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015 - 01/2015
2	TOR Serine-Threonine KinasesIBA 01/2015 - 01/2015
2	CaspasesIBA 01/2015 - 01/2015
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2015 - 01/2015
2	Glutathione (Reduced Glutathione)IBA 01/2014 - 01/2013

Therapy/Procedure

11	Therapeutics 01/2020 - 05/2009
9	Drug Therapy (Chemotherapy) 01/2020 - 01/2007